ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study

Yang, Lihong; Chen, Xueyin; Li, Chuang; Xu, Peng; Mao, Wei; Liang, Xing; Zuo, Qi; Ma, Weizhong; Guo, Xinfeng*; Bao, Kun*广东省人民医院; 广州中医药大学
Frontiers in Pharmacology2022-1-3DOI: 10.3389/fphar.2021.760482
2被引6阅读
引用收藏
分享

摘要

Introduction: Some encouraging findings of Chinese herbal medicine (CHM) in management of idiopathic membranous nephropathy (IMN) obtained in the setting of clinical trials are hard to validate in the daily clinical practice due to a complicated treatment scenario of CHM in practice. The primary objective of this registry is to provide a description of treatment patterns used in management of IMN and assess clinical remission in daily practice in a Chinese population sample with IMN.Methods and analysis: This is a prospective, multicenter cohort which will comprise 2000 adults with IMN regardless of urinary protein levels that will be recruited from 11 nephrology centers across China. The participants will be followed for up to at least 2 years. Primary outcome is composite remission (either complete remission or partial remission) 24 months after enrolment. The secondary outcomes are complete remission, partial remission, time to remission, no response, relapse, proteinuria, annual change of glomerular filtration rate, antibodies against PLA2R, and composite endpoint of 40% reduction of glomerular filtration rate, doubling of serum creatinine, end-stage renal disease, and death. Propensity score analysis will be used for matching and adjustment.Ethics and dissemination: This study has been approved by the Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine (BF2020-094-01). Results of the study will be published in both national and international peer-reviewed journals, and presented at scientific conferences. Investigators will inform the participants as well as other IMN patients of the findings via health education.Study registration: ChiCTR2000033680 (prospectively registered).

学科与关键词

关键词
idiopathic membranous nephropathyChinese herbal medicinecohort studyprotocolregistry
相关
加载中…
  • The efficacy and safety of Sanqi Qushi Granule in patients with idiopathic membranous nephropathy --protocol of a multicenter, randomized control trial (SQ-AUTUMN)
    Li, Chuang; Shan, Wenjun; Liang, Xing; Zhang, Qinghua; Qin, Xindong; Jiang, Sha; Hong, Xiaofan; Wang, Lijuan; Li, Ping; Gu, Haowen; Wang, Yi; Bao, Kun*BMC Complementary Medicine and Therapies, 2023, 23(1): 134.
  • Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis
    Wang, Dan; Wang, Lijuan; Zhang, Mingrui; Li, Ping; Zhang, Qinghua; Bao, Kun*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(9).
  • Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy
    Liang, Jinxiu; Hao, Wenke; Xia, Fangxiao; Zhao, Zhi; Wu, Yanhua; Yu, Feng; Hu, Wenxue; Fang, Xiaowu; Liu, Wei*RENAL FAILURE, 2023, 45(1): 2212081.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-01-03
卷期
第 12 卷
页码
760482
DOI
10.3389/fphar.2021.760482
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81974565]; Special project of State Key Laboratory of Dampness Syndrome of Chinese Medicine [2019KT1144, SZ2020ZZ24, SZ2021ZZ04, SZ2021ZZ36, SZ2021ZZ09]; Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases [2018B030322012]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund from Guangdong-Hong Kong-Macau Joint Lab [2020B1212030006]; Guangdong province science and technology plan project [202102010212]

作者

  • Y

    Yang, Lihong (第一作者)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chen, Xueyin

    2 · guangdong prov hosp · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • L

    Li, Chuang

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • X

    Xu, Peng

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • M

    Mao, Wei

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • L

    Liang, Xing

    guangdong prov hosp

  • Z

    Zuo, Qi

    guangdong prov hosp

  • M

    Ma, Weizhong

    guangdong prov hosp

  • G

    Guo, Xinfeng (通讯)

    2 · guangzhou univ chinese med · guangdong prov hosp

  • B

    Bao, Kun (通讯)

    guangdong prov hosp · 2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417